Fund Details
Overview
Investment portfolio
4rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Semarion | Mar 2026Participated | $4 MOther Equity | |
HotHouse Therapeutics | Dec 2025Participated | $4 MSeed | |
TRIMTECH Therapeutics | Mar 2025Participated | $34 MSeed | |
NK:IO | Jul 2023Participated | $2 MOther Equity | |
Semarion | Mar 2026Participated | $4 MOther Equity | |
HotHouse Therapeutics | Dec 2025Participated | $4 MSeed | |
TRIMTECH Therapeutics | Mar 2025Participated | $34 MSeed | |
NK:IO | Jul 2023Participated | $2 MOther Equity |
4 Items
4
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 2 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 4 |
| Food & Agriculture | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 3 |
| United States | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Cambridge Enterprise | 2 |
| Cambridge Capital Group | 1 |
| Cambridge Innovation Capital | 1 |
| Cancer Research Horizons | 1 |
| Eli Lilly and Company | 1 |
| Found Capital | 1 |
| Imperial College | 1 |
| M Ventures | 1 |
| Meltwind | 1 |
| MP Healthcare Venture Management | 1 |
| Oxford Innovation Finance | 1 |
| Parkwalk Advisors | 1 |
| Pfizer Ventures | 1 |
| SV Health Investors | 1 |
| SynBioVen | 1 |
| The FSE Group | 1 |
| Twin Path Ventures | 1 |
| UK Innovation & Science Seed Fund | 1 |
| UKI2S | 1 |
| Wren Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 4 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range